Take a fresh look at your lifestyle.

Almirall raises after selling its medicine Ansiolin to Neuraxpharm in Italy


Almirall has sold its medicine Ansiolin to Neuraxpharm in Italy, as reported by the company, which for the moment You have not disclosed what your sale price will be. The shares of Almirall have advanced 2.27% this Friday and have positioned themselves as the most bullish on the Ibex.

For Bankinter analysts, this operation is not a great move for Almirall, since "it is possibly a divestment made at a very low price"

This drug, intended to treat anxiety, stress and insomnia, does not appear in the list of best-selling products de Almirall, since its sales must be less than 2% of the total.

Since June 22, Almirall entered be part of the companies listed on the Ibex 35 by meeting the technical criteria required for joining the selective. It has a capitalization of over 2,200 million euros.


Leave A Reply

Your email address will not be published.